Cardiovascular Health Improvement Project

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

9999 participants

Study Classification

OBSERVATIONAL

Study Start Date

2013-08-31

Study Completion Date

2053-08-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Cardiovascular Biorepository

NCT00753974

Cardiovascular Diseases

ENROLLING_BY_INVITATION

Molecular and Imaging Studies of Cardiovascular Health and Disease

NCT02804269

Healthy Dilated Cardiomyopathy Hypertrophic Cardiomyopathy +1 more

RECRUITING

Prospective Project to Identify Biomarkers of Morbidity and Mortality in Cardiovascular Interventional Patients

NCT03444259

Atrial Fibrillation Coronary Artery Disease Aortic Valve Stenosis +5 more

ACTIVE_NOT_RECRUITING

Study of Value of Cardiac PET Scans With or Without CT Angiography and/or Measurement of Coronary Flow Reserve

NCT00669968

Chest Pain Coronary Artery Disease

COMPLETED

Cardiology Biobank Registry

NCT00378924

Cardiovascular Disease

RECRUITING

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The goal of this project is to establish a biobank of clinical information, DNA, plasma, and aortic tissue samples from patients with cardiovascular disease as well as healthy controls. The aims of the study are to collect biological specimens (blood, plasma, serum, aortic tissue) and family history; establish a biobank, establish a comprehensive database with information from consented patients, and provide researchers with high quality well annotated DNA samples with demographic and clinical information.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Aortic Aneurysm Aortic Dissection Bicuspid Aortic Valve (BAV) Heart Failure Cardiovascular Diseases

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

CASE_CONTROL

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Aortic Disease

Patients with a diagnosis of any form of Aortic Disease

No interventions assigned to this group

Controls

Patients without a diagnosis of Aortic Disease

No interventions assigned to this group

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Any patient over the age of 18 who is able/willing to give informed consent
* Patients \<18 years of age with parental consent and assent (if assent is applicable for their age)
* Diagnosis of:
* aortic pathology potentially due to a known or suspected inherited condition
* Idiopathic aortic aneurysm
* Interesting of novel vascular pathology in the aorta or main branches
* Family history of aortic or vascular disease
* Other cardiovascular disease
* Healthy controls with no apparent cardiovascular disease